CD44 and cancer: Although the pleiotropic effects exerted by CD44 in exosome biogenesis and function in cancer and chronic kidney disease have been investigated (Chen et al. 2022; Kelemen et al. 2022; Shen et al. 2021), the role of CD44 in exosomes under MI injury is still poorly understood.